MS to NMOSD Reclassification — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Reclassify to AQP4-positive NMOSD — stop MS DMTs as they may worsen NMOSD
LETM with AQP4 positivity is NMOSD. MS DMTs (interferon, fingolimod) worsen NMOSD. Switch to rituximab, eculizumab, or satralizumab. A: Must change treatment. C: Natalizumab worsens NMOSD. D: Diagnosis changed. E: Delaying risks attacks.
Reference: ABN NMOSD Guidelines